HemaCore was founded in 2010 as a biotech company focused on developing, manufacturing and implementing new technology for hemostasis – thrombodynamics.
Thrombodynamics assay – an innovative coagulation test for risk assessment of blood coagulation disorders – bleedings and thrombosis.
HemaCore helps provide clear and reliable estimation of a subject’s coagulation state, thus giving an ability to prevent thrombotic or bleeding complications.
